Annual FCF
-$7.21 M
-$4.14 M-134.48%
December 31, 2023
Summary
- As of February 25, 2025, ANIK annual free cash flow is -$7.21 million, with the most recent change of -$4.14 million (-134.48%) on December 31, 2023.
- During the last 3 years, ANIK annual FCF has fallen by -$18.65 million (-163.08%).
- ANIK annual FCF is now -118.78% below its all-time high of $38.42 million, reached on December 31, 2014.
Performance
ANIK Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
$3.20 M
+$7.67 M+171.56%
September 30, 2024
Summary
- As of February 25, 2025, ANIK quarterly free cash flow is $3.20 million, with the most recent change of +$7.67 million (+171.56%) on September 30, 2024.
- Over the past year, ANIK quarterly FCF has stayed the same.
- ANIK quarterly FCF is now -83.52% below its all-time high of $19.42 million, reached on March 31, 2004.
Performance
ANIK Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$1.41 M
-$2.54 M-223.94%
September 30, 2024
Summary
- As of February 25, 2025, ANIK TTM free cash flow is -$1.41 million, with the most recent change of -$2.54 million (-223.94%) on September 30, 2024.
- Over the past year, ANIK TTM FCF has stayed the same.
- ANIK TTM FCF is now -103.66% below its all-time high of $38.42 million, reached on December 31, 2014.
Performance
ANIK TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ANIK Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -134.5% | 0.0% | 0.0% |
| 3 y3 years | -163.1% | +311.3% | -168.8% |
| 5 y5 years | -123.8% | -66.8% | -104.1% |
ANIK Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -321.7% | at low | -44.3% | +132.8% | -143.3% | +91.1% |
| 5 y | 5-year | -121.1% | at low | -74.9% | +132.8% | -104.1% | +91.1% |
| alltime | all time | -118.8% | +43.8% | -83.5% | +130.1% | -103.7% | +94.0% |
Anika Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $3.20 M(-171.6%) | -$1.41 M(-223.9%) |
| Jun 2024 | - | -$4.47 M(+131.2%) | $1.14 M(-127.4%) |
| Mar 2024 | - | -$1.93 M(-207.6%) | -$4.14 M(-42.6%) |
| Dec 2023 | -$7.21 M(+134.5%) | $1.80 M(-68.7%) | -$7.21 M(-34.8%) |
| Sep 2023 | - | $5.74 M(-158.9%) | -$11.06 M(-29.9%) |
| Jun 2023 | - | -$9.75 M(+94.7%) | -$15.79 M(+222.9%) |
| Mar 2023 | - | -$5.01 M(+144.5%) | -$4.89 M(+58.9%) |
| Dec 2022 | -$3.08 M(-194.6%) | -$2.05 M(-301.2%) | -$3.08 M(-232.9%) |
| Sep 2022 | - | $1.02 M(-11.3%) | $2.32 M(+11.6%) |
| Jun 2022 | - | $1.15 M(-135.9%) | $2.08 M(-28.6%) |
| Mar 2022 | - | -$3.19 M(-195.5%) | $2.91 M(-10.7%) |
| Dec 2021 | $3.25 M(-71.5%) | $3.35 M(+329.9%) | $3.25 M(+59.0%) |
| Sep 2021 | - | $778.00 K(-60.7%) | $2.05 M(-70.2%) |
| Jun 2021 | - | $1.98 M(-169.5%) | $6.86 M(-17.0%) |
| Mar 2021 | - | -$2.85 M(-233.2%) | $8.27 M(-27.7%) |
| Dec 2020 | $11.44 M(-66.5%) | $2.14 M(-61.8%) | $11.44 M(-48.1%) |
| Sep 2020 | - | $5.59 M(+65.4%) | $22.05 M(-15.4%) |
| Jun 2020 | - | $3.38 M(+950.6%) | $26.08 M(-3.6%) |
| Mar 2020 | - | $322.00 K(-97.5%) | $27.07 M(-20.8%) |
| Dec 2019 | $34.18 M(+12.9%) | $12.75 M(+32.5%) | $34.18 M(+9.3%) |
| Sep 2019 | - | $9.62 M(+120.3%) | $31.27 M(-0.0%) |
| Jun 2019 | - | $4.37 M(-41.2%) | $31.28 M(+2.1%) |
| Mar 2019 | - | $7.43 M(-24.5%) | $30.64 M(+1.3%) |
| Dec 2018 | $30.26 M(-4.9%) | $9.85 M(+2.3%) | $30.26 M(+21.4%) |
| Sep 2018 | - | $9.63 M(+158.2%) | $24.92 M(+0.5%) |
| Jun 2018 | - | $3.73 M(-47.1%) | $24.80 M(-1.2%) |
| Mar 2018 | - | $7.05 M(+56.4%) | $25.10 M(-21.2%) |
| Dec 2017 | $31.83 M(+205.1%) | $4.51 M(-52.6%) | $31.83 M(-0.5%) |
| Sep 2017 | - | $9.51 M(+136.1%) | $31.99 M(+3.0%) |
| Jun 2017 | - | $4.03 M(-70.8%) | $31.05 M(+37.5%) |
| Mar 2017 | - | $13.79 M(+195.6%) | $22.59 M(+116.5%) |
| Dec 2016 | $10.43 M(-66.0%) | $4.66 M(-45.6%) | $10.43 M(-29.0%) |
| Sep 2016 | - | $8.58 M(-293.5%) | $14.69 M(+4.0%) |
| Jun 2016 | - | -$4.43 M(-372.6%) | $14.13 M(-50.6%) |
| Mar 2016 | - | $1.63 M(-81.8%) | $28.58 M(-6.9%) |
| Dec 2015 | $30.69 M(-20.1%) | $8.92 M(+11.4%) | $30.69 M(-14.5%) |
| Sep 2015 | - | $8.01 M(-20.1%) | $35.88 M(+2.5%) |
| Jun 2015 | - | $10.02 M(+168.8%) | $35.02 M(+21.4%) |
| Mar 2015 | - | $3.73 M(-73.6%) | $28.83 M(-25.0%) |
| Dec 2014 | $38.42 M(+55.4%) | $14.12 M(+97.7%) | $38.42 M(+19.7%) |
| Sep 2014 | - | $7.14 M(+86.0%) | $32.10 M(-0.8%) |
| Jun 2014 | - | $3.84 M(-71.2%) | $32.36 M(+1.1%) |
| Mar 2014 | - | $13.32 M(+70.8%) | $32.01 M(+29.5%) |
| Dec 2013 | $24.72 M(+173.4%) | $7.80 M(+5.4%) | $24.72 M(+14.9%) |
| Sep 2013 | - | $7.40 M(+112.0%) | $21.52 M(+33.0%) |
| Jun 2013 | - | $3.49 M(-42.2%) | $16.18 M(-4.8%) |
| Mar 2013 | - | $6.03 M(+31.1%) | $16.99 M(+87.9%) |
| Dec 2012 | $9.04 M(+3.1%) | $4.60 M(+123.9%) | $9.04 M(-20.0%) |
| Sep 2012 | - | $2.05 M(-52.3%) | $11.30 M(-5.2%) |
| Jun 2012 | - | $4.30 M(-324.9%) | $11.93 M(+111.1%) |
| Mar 2012 | - | -$1.91 M(-127.9%) | $5.65 M(-35.6%) |
| Dec 2011 | $8.77 M(+73.1%) | $6.86 M(+156.2%) | $8.77 M(+86.1%) |
| Sep 2011 | - | $2.68 M(-235.6%) | $4.71 M(+3.9%) |
| Jun 2011 | - | -$1.98 M(-263.4%) | $4.54 M(-35.6%) |
| Mar 2011 | - | $1.21 M(-56.8%) | $7.04 M(+39.0%) |
| Dec 2010 | $5.07 M(-684.3%) | $2.80 M(+12.1%) | $5.07 M(+3.8%) |
| Sep 2010 | - | $2.50 M(+369.0%) | $4.88 M(+178.9%) |
| Jun 2010 | - | $533.00 K(-169.6%) | $1.75 M(+138.7%) |
| Mar 2010 | - | -$766.00 K(-129.3%) | $733.40 K(-184.5%) |
| Dec 2009 | -$867.50 K(-93.2%) | $2.62 M(-513.7%) | -$867.60 K(-76.4%) |
| Sep 2009 | - | -$632.40 K(+30.5%) | -$3.67 M(-26.1%) |
| Jun 2009 | - | -$484.50 K(-79.5%) | -$4.97 M(-50.8%) |
| Mar 2009 | - | -$2.37 M(+1180.2%) | -$10.09 M(-21.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2008 | -$12.84 M(+25.1%) | -$184.90 K(-90.4%) | -$12.84 M(-44.9%) |
| Sep 2008 | - | -$1.93 M(-65.6%) | -$23.30 M(+14.8%) |
| Jun 2008 | - | -$5.61 M(+9.7%) | -$20.30 M(+36.0%) |
| Mar 2008 | - | -$5.11 M(-52.0%) | -$14.93 M(+45.4%) |
| Dec 2007 | -$10.26 M(-1575.8%) | -$10.65 M(-1088.5%) | -$10.26 M(+5880.7%) |
| Sep 2007 | - | $1.08 M(-544.4%) | -$171.60 K(-70.8%) |
| Jun 2007 | - | -$242.40 K(-46.1%) | -$586.80 K(-154.0%) |
| Mar 2007 | - | -$449.90 K(-19.2%) | $1.09 M(+56.4%) |
| Dec 2006 | $695.40 K(-85.7%) | -$556.50 K(-184.1%) | $695.30 K(+750.0%) |
| Sep 2006 | - | $662.00 K(-53.8%) | $81.80 K(-98.5%) |
| Jun 2006 | - | $1.43 M(-270.0%) | $5.35 M(+70.1%) |
| Mar 2006 | - | -$842.10 K(-28.0%) | $3.15 M(-35.2%) |
| Dec 2005 | $4.85 M(-79.2%) | -$1.17 M(-119.7%) | $4.85 M(-56.6%) |
| Sep 2005 | - | $5.93 M(-866.0%) | $11.17 M(+101.7%) |
| Jun 2005 | - | -$774.40 K(-189.7%) | $5.54 M(+15.4%) |
| Mar 2005 | - | $863.50 K(-83.2%) | $4.80 M(-79.5%) |
| Dec 2004 | $23.35 M(+1229.8%) | $5.15 M(+1621.8%) | $23.35 M(+12.7%) |
| Sep 2004 | - | $299.00 K(-119.7%) | $20.72 M(-4.6%) |
| Jun 2004 | - | -$1.51 M(-107.8%) | $21.72 M(+0.1%) |
| Mar 2004 | - | $19.42 M(+671.5%) | $21.69 M(+1135.0%) |
| Dec 2003 | $1.76 M(+622.6%) | $2.52 M(+94.1%) | $1.76 M(+189.3%) |
| Sep 2003 | - | $1.30 M(-183.9%) | $607.00 K(-192.9%) |
| Jun 2003 | - | -$1.55 M(+202.0%) | -$653.40 K(-290.7%) |
| Mar 2003 | - | -$512.00 K(-137.4%) | $342.70 K(+41.0%) |
| Dec 2002 | $243.00 K(-104.7%) | $1.37 M(+3637.7%) | $243.00 K(-112.2%) |
| Sep 2002 | - | $36.60 K(-106.7%) | -$2.00 M(-46.9%) |
| Jun 2002 | - | -$549.90 K(-10.1%) | -$3.76 M(-13.3%) |
| Mar 2002 | - | -$611.70 K(-29.7%) | -$4.33 M(-17.0%) |
| Dec 2001 | -$5.22 M(+118.6%) | -$870.30 K(-49.6%) | -$5.22 M(+30.0%) |
| Sep 2001 | - | -$1.73 M(+53.3%) | -$4.02 M(+15.2%) |
| Jun 2001 | - | -$1.13 M(-24.9%) | -$3.49 M(+5.6%) |
| Mar 2001 | - | -$1.50 M(-547.0%) | -$3.30 M(+38.3%) |
| Dec 2000 | -$2.39 M(+157.5%) | $335.50 K(-128.0%) | -$2.39 M(-24.2%) |
| Sep 2000 | - | -$1.20 M(+27.0%) | -$3.15 M(+39.7%) |
| Jun 2000 | - | -$941.80 K(+60.7%) | -$2.26 M(-6.6%) |
| Mar 2000 | - | -$585.90 K(+37.0%) | -$2.41 M(+160.2%) |
| Dec 1999 | -$927.70 K(-177.3%) | -$427.70 K(+42.6%) | -$927.70 K(+827.7%) |
| Sep 1999 | - | -$300.00 K(-72.7%) | -$100.00 K(-110.0%) |
| Jun 1999 | - | -$1.10 M(-222.2%) | $1.00 M(-67.7%) |
| Mar 1999 | - | $900.00 K(+125.0%) | $3.10 M(+158.3%) |
| Dec 1998 | $1.20 M(-47.8%) | $400.00 K(-50.0%) | $1.20 M(-65.7%) |
| Sep 1998 | - | $800.00 K(-20.0%) | $3.50 M(+34.6%) |
| Jun 1998 | - | $1.00 M(-200.0%) | $2.60 M(+36.8%) |
| Mar 1998 | - | -$1.00 M(-137.0%) | $1.90 M(-26.9%) |
| Dec 1997 | $2.30 M(-330.0%) | $2.70 M(-2800.0%) | $2.60 M(-360.0%) |
| Sep 1997 | - | -$100.00 K(-133.3%) | -$1.00 M(-33.3%) |
| Jun 1997 | - | $300.00 K(-200.0%) | -$1.50 M(-21.1%) |
| Mar 1997 | - | -$300.00 K(-66.7%) | -$1.90 M(-17.4%) |
| Dec 1996 | -$1.00 M(-50.0%) | - | - |
| Nov 1996 | - | -$900.00 K(+50.0%) | -$2.30 M(+15.0%) |
| Aug 1996 | - | -$600.00 K(+500.0%) | -$2.00 M(+11.1%) |
| Aug 1996 | -$2.00 M(0.0%) | - | - |
| May 1996 | - | -$100.00 K(-85.7%) | -$1.80 M(-21.7%) |
| Feb 1996 | - | -$700.00 K(+16.7%) | -$2.30 M(+15.0%) |
| Nov 1995 | - | -$600.00 K(+50.0%) | -$2.00 M(0.0%) |
| Aug 1995 | -$2.00 M(-23.1%) | -$400.00 K(-33.3%) | -$2.00 M(-16.7%) |
| May 1995 | - | -$600.00 K(+50.0%) | -$2.40 M(+20.0%) |
| Feb 1995 | - | -$400.00 K(-33.3%) | -$2.00 M(-23.1%) |
| Nov 1994 | - | -$600.00 K(-25.0%) | -$2.60 M(0.0%) |
| Aug 1994 | -$2.60 M(+36.8%) | -$800.00 K(+300.0%) | -$2.60 M(+44.4%) |
| May 1994 | - | -$200.00 K(-80.0%) | -$1.80 M(+12.5%) |
| Feb 1994 | - | -$1.00 M(+66.7%) | -$1.60 M(+166.7%) |
| Nov 1993 | - | -$600.00 K | -$600.00 K |
| Aug 1993 | -$1.90 M | - | - |
FAQ
- What is Anika Therapeutics annual free cash flow?
- What is the all time high annual FCF for Anika Therapeutics?
- What is Anika Therapeutics annual FCF year-on-year change?
- What is Anika Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Anika Therapeutics?
- What is Anika Therapeutics quarterly FCF year-on-year change?
- What is Anika Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Anika Therapeutics?
- What is Anika Therapeutics TTM FCF year-on-year change?
What is Anika Therapeutics annual free cash flow?
The current annual FCF of ANIK is -$7.21 M
What is the all time high annual FCF for Anika Therapeutics?
Anika Therapeutics all-time high annual free cash flow is $38.42 M
What is Anika Therapeutics annual FCF year-on-year change?
Over the past year, ANIK annual free cash flow has changed by -$4.14 M (-134.48%)
What is Anika Therapeutics quarterly free cash flow?
The current quarterly FCF of ANIK is $3.20 M
What is the all time high quarterly FCF for Anika Therapeutics?
Anika Therapeutics all-time high quarterly free cash flow is $19.42 M
What is Anika Therapeutics quarterly FCF year-on-year change?
Over the past year, ANIK quarterly free cash flow has changed by $0.00 (0.00%)
What is Anika Therapeutics TTM free cash flow?
The current TTM FCF of ANIK is -$1.41 M
What is the all time high TTM FCF for Anika Therapeutics?
Anika Therapeutics all-time high TTM free cash flow is $38.42 M
What is Anika Therapeutics TTM FCF year-on-year change?
Over the past year, ANIK TTM free cash flow has changed by $0.00 (0.00%)